Actemra 160mg, a treatment known scientifically as tocilizumab, is a a potent biologic agent primarily used for the management of rheumatoid arthritis. This powerful agent acts by interfering with the activity of interleukin-6 (IL-6), a communication protein essential in the inflammatory process. Additionally, Actemra demonstrates effectiveness in